Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | XBP1 | P17861 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | CTSS | P25774 | 1/20 | 0.30 |
| ▸ | CTSK | P43235 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12813009 | 0.83 | ALDH1A1 (0.55) | ALDH1A1LMNAMAPK1TDP1MAPT | |
| SCHEMBL3623365 | 0.79 | ALDH1A1 (0.52) | ALDH1A1LMNAMAPK1TDP1MAPT | |
| SCHEMBL2727463 | 0.78 | ALDH1A1 (0.52) | ALDH1A1LMNAMAPK1TDP1MAPT | |
| SCHEMBL13294367 | 0.78 | ALDH1A1 (0.51) | ALDH1A1LMNAMAPK1TDP1MAPT | |
| SCHEMBL15826369 | 0.78 | ALDH1A1 (0.52) | ALDH1A1LMNAMAPK1TDP1MAPT | |
| SCHEMBL22431609 | 0.78 | ALDH1A1 (0.55) | ALDH1A1LMNAMAPK1TDP1MAPT | |
| SCHEMBL29664901 | 0.78 | ALDH1A1 (0.55) | ALDH1A1LMNAMAPK1TDP1MAPT | |
| SCHEMBL14484071 | 0.76 | ALDH1A1 (0.52) | ALDH1A1LMNAMAPK1TDP1MAPT | |
| SCHEMBL5613465 | 0.76 | ALDH1A1 (0.49) | ALDH1A1LMNAMAPK1TDP1MAPT | |
| SCHEMBL25208359 | 0.75 | ALDH1A1 (0.51) | ALDH1A1LMNAMAPK1TDP1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7235587-B2 | Diesters containing two crylene or fluorene moieties, sunscreen compositions containing the same, and methods of photostabilizing a sunscreen compositions containing the same | CPH INNOVATIONS CORPORATION (US) | 2007-06-26 | — | — | US | disclosed |
| US-20060002869-A1 | Diesters containing two crylene or fluorene moieties, sunscreen compositions containing the same, and methods of photostabilizing a sunscreen compositions containing the same | BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT | 2006-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060002869-A1 | Diesters containing two crylene or fluorene moieties, sunscreen compositions containing the same, and methods of photostabilizing a sunscreen compositions containing the same | CRYZ, CRY2, CRYAA | ALDH1A1 2022/4885LMNA 987/4885MAPK1 4061/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.